DYNAMICS OF GROWTH IN CHILDREN WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB

被引：0
|
作者：
Seraya, V. [1 ]
Zholobova, E. [1 ]
Vitebskaya, A. [1 ]
机构：
[1] IM Sechenov First Moscow State Med Univ, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.2493
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0887
引用
收藏
页码：1205 / 1206
页数：2
相关论文
共 50 条
  • [41] SUCCESSFUL RAPID TOCILIZUMAB DESENSITIZATION IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
    Villarreal Gonzalez, R.
    Gonzalez-Diaz, S.
    Arias-Cruz, A.
    Macias-Weinmann, A.
    De Lira-Quezada, C.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S70 - S70
  • [42] Safety and efficacy Tocilizumab therapy in children with juvenile idiopathic arthritis
    Alexeeva, Ekaterina
    Denisova, Rina
    Bzarova, Tatyana
    Valiyeva, Saniya
    Isayeva, Kseniya
    Lisitsyn, Alexander
    Tatyana, Sleptsova
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 386 - 386
  • [43] Efficacy and Safety of Tocilizumab in Patients with Severe Systemic Juvenile Idiopathic Arthritis
    Alekseeva, Ekaterina I.
    Denisova, Rina V.
    Valieva, Saniya I.
    Bsarova, Tatyana M.
    Isaeva, Kseniya B.
    Chistyakova, Evgeniya G.
    Sleptsova, Tatyana V.
    Mitenko, Elena V.
    [J]. INTERNATIONAL JOURNAL OF BIOMEDICINE, 2011, 1 (04) : 190 - 198
  • [44] Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (06) : 387 - 397
  • [45] Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
    Kearsley-Fleet, Lianne
    Beresford, Michael W.
    Davies, Rebecca
    De Cock, Diederik
    Baildam, Eileen
    Foster, Helen E.
    Southwood, Taunton R.
    Thomson, Wendy
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2019, 58 (01) : 94 - 102
  • [46] Reported Macrophage Activation Syndrome In Patients With Systemic-Onset Juvenile Idiopathic Arthritis Treated With Tocilizumab
    Yokota, Shumpei
    Itoh, Yasuhiko
    Morio, Tomohiro
    Sumitomo, Naokata
    Minota, Seiji
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S114 - S114
  • [47] ECONOMIC EVALUATION OF TOCILIZUMAB FOR THE TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN MEXICO
    Carlos, F.
    Clark, P.
    Lechuga, D.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A309 - A309
  • [48] EXPERIENCE WITH TOCILIZUMAB IN 29 PATIENTS WITH SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Horneff, G.
    Onken, N.
    Hospach, A.
    Ganser, G.
    Huppertz, H. I.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 737 - 738
  • [49] A Bullseye for Children With Systemic Juvenile Idiopathic Arthritis
    Henderson, Lauren A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71 (07) : 1030 - 1033
  • [50] Tocilizumab for rheumatoid and juvenile idiopathic arthritis
    Bongartz, Tim
    [J]. LANCET, 2008, 371 (9617): : 961 - 963
12345